(Q45369715)

13 December 2017

Occult hepatitis B virus infection in Thai blood donors (English)

1 reference

13 December 2017

1 reference

Suda Louisirirotchanakul

1

1 reference

13 December 2017

Sineenart Oota

2

1 reference

13 December 2017

Kalayanee Khuponsarb

3

1 reference

13 December 2017

Wilai Chalermchan

4

1 reference

13 December 2017

Soisaang Phikulsod

5

1 reference

13 December 2017

Viroje Chongkolwatana

6

1 reference

13 December 2017

Tasanee Sakuldamrongpanish

7

1 reference

13 December 2017

Pimpun Kitpoka

8

1 reference

13 December 2017

Pimol Chielsilp

9

1 reference

13 December 2017

Srivilai Tanprasert

10

1 reference

13 December 2017

Thaweesak Tirawatnapong

11

1 reference

13 December 2017

Chantapong Wasi

12

1 reference

13 December 2017

Working Group for NAT Study in Thai Blood Donations

13

1 reference

13 December 2017

20 January 2011

1 reference

13 December 2017

1 reference

13 December 2017

51

1 reference

13 December 2017

7

1 reference

13 December 2017

1532-1540

1 reference

One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations

13 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Occult hepatitis B virus infection: implications in transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Occult hepatitis B infection: an evolutionary scenario

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Hepatitis B virus infection and transfusion medicine: science and the occult

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Prevalence of hepatitis B and C virus infection in rural ethnic populations of Northern Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Hepatitis B virus blood screening: unfinished agendas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Anti HCV seroprevalence among the voluntary blood donors in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

PRISM hepatitis B surface antigen detection of hepatits B virus minipool nucleic acid testing yield samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Molecular characterization of occult hepatitis B cases in Greek blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Italian blood donors with anti-HBc and occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Persistent occult hepatitis B virus infection: experimental findings and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Transient occult hepatitis B virus infection in a blood donor with high viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Hepatitis B virus genotype G monoinfection and its transmission by blood components

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

A new method of concentrating hepatitis B virus (HBV) DNA and HBV surface antigen: an application of the method to the detection of occult HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Cost-effectiveness of additional hepatitis B virus nucleic acid testing of individual donations or minipools of six donations in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

Occult hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2010.03023.X

10.1111/J.1537-2995.2010.03023.X

21 January 2018

Identifiers

DOI

1 reference

13 December 2017

1 reference